Safety and Efficacy of Study molecule in the Treatment of patients with Psychosis associated with Parkinson’s disease.

A Randomized, Double-blind, Parallel-Group, Comparative Study of Flexible Doses of Paliperidone Palmitate and Flexible Doses of Schizophrenia Pre-study status. Risperidone Long-Acting Intramuscluar Injection in subjects with. Dr. Keshav Pai – Principle Investigator, Dr. Mariella D’Souza – Rater.

Phase 3: A Randomized, Double-Blind, Placebo – and active controlled, parallel-group, study to evaluate the efficacy and safety of Risperidone long acting injectable for the prevention of mood episodes in the treatment of subjects with Bipolar I Disorder.

A short term project on “Evaluation tolerability safety of Memantine and Donepezil in moderate to severe Alzheimer’s disease as monotherapy and in combination”.

As a Primary investigator for Randomized, Double-Blinded, Placebo-Controlled, Risperidone – Referenced, Parallel-Group, Adaptive – Design study of the Efficacy, Safety and Tolerability of study molecule in subjects with Acute Exacerbations of Schizophrenia.

As a Primary investigator for a Double Blind, multinational, multicentre, placebo-controlled co-week study assessing the efficacy and safety of study molecule flexible dose in the treatment of patients with Major Depressive Disorder. Dr. Keshav Pai- Principle Investigator, Dr. Mariella D’Souza – Rater

As Co-Investigator for A randomized, double blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of study molecule ER compared to quetiapine in subjects with an acute exacerbation schizophrenia.

Schizophrenia, Pediatric Psychiatry

Childhood Behaviour Disorders, Youth Violence, addictive behaviours, Post Partum Women

A study on the Determinants of the Quality of life and Burden among wives of HIV/AIDS infected husbands.

Schizophrenia-Psychopharmacology.